Healthcare
News Category

Visory Health Named to Fast Company's 2026 Best Workplaces for Innovators List
Visory Health's inclusion on Fast Company's 2026 Best Workplaces for Innovators list highlights its innovative culture and commitment to prescription ...

New Stroke Rehabilitation Guideline Emphasizes Early, Personalized, and Long-Term Recovery
The American Stroke Association's 2026 guideline stresses that stroke rehabilitation should start within 48 hours and continue indefinitely, focusing ...

Earth Science Tech Leverages Vertical Integration to Build Self-Sustaining Healthcare Conglomerate
Earth Science Tech Inc. reports financial strength for fiscal 2027, driven by its conglomerate model and end-to-end vertical integration across teleme...

Kairos Pharma CEO to Present at Major Investment Conference Amid Advances in Cancer Drug Resistance
Kairos Pharma's CEO will present at the H.C. Wainwright conference, highlighting its lead candidate ENV-105 designed to overcome cancer drug resistanc...

Expert Warns of Hidden Crisis in UTI Diagnosis, Urging Better Testing
An expert highlights the overlooked complexities of urinary tract infections (UTIs), stressing the need for advanced diagnostic tools to prevent misdi...

Nutriband CEO to Present at Nasdaq Biotech Summit, Highlighting Abuse-Deterrent Patch Technology
Nutriband's CEO will attend the Nasdaq LaB Biotech Summit, showcasing its AVERSA technology aimed at preventing opioid abuse, a critical issue in publ...

Silo Pharma to Present at Nasal Drug Delivery Forum as SPC-15 Stability Data Supports PTSD Treatment
Silo Pharma's participation in the IPAC-RS 2026 Nasal Innovation Forum highlights progress in its nose-to-brain drug delivery platform, with new stabi...

Quantum BioPharma's Lucid-MS Gets FDA Clearance for Phase 2 Trial, Highlighted in BioMedWire Editorial
Quantum BioPharma announced FDA clearance for its Phase 2 trial of Lucid-MS, a first-in-class candidate for multiple sclerosis, which has drawn analys...

Helus Pharma CEO to Present at H.C. Wainwright Conference, Highlighting Phase 3 Depression Drug
Helus Pharma's CEO participation in a major investment conference underscores the company's progress in developing novel treatments for depression and...

Moody Capital's 2026 Conference to Spotlight Under-Covered Growth and Life Sciences Firms
Moody Capital Solutions will host its 2026 Disruptive Growth & Life Sciences Conference, a two-day event focused on company presentations and schedule...

GeoVax Welcomes Global Mpox Vaccine Stockpile, Emphasizes Need for Diversified Supply
GeoVax applauds the new Gavi-funded global mpox vaccine stockpile as a step toward sustained preparedness, while highlighting its GEO-MVA candidate's ...

Translational Longevity Takes Center Stage as August Wellness Index Report Highlights Path from Discovery to Delivery
The August Wellness Index Report underscores the critical role of translational longevity—turning lab breakthroughs into real patient care—and preview...

Greenland Mines to Spin Off Biotech Division, Focus on Rare Earths
Greenland Mines announces Q4 biotech spin-off, Nasdaq compliance, and Sarfartoq acquisition, positioning itself as a key rare earths supplier outside ...

Nano-X Imaging Expands Nanox.ARC Distribution in New England Through Partnership with Associated X-Ray Imaging
Nano-X Imaging has signed a distribution agreement with Associated X-Ray Imaging Corp. to market and support its Nanox.ARC system in New England, aimi...

SS Innovations Scales Surgical Robotics Globally as Revenue Jumps 39.4%
SS Innovations International reports strong second-quarter growth and global expansion of its SSi Mantra surgical robotic system, positioning itself f...

Scinai Immunotherapeutics Streamlines Operations to Prioritize NanoAb Platform and CDMO Growth
Scinai Immunotherapeutics has ended its PC111 license agreement with PinCell to focus resources on its NanoAb platform and expanding CDMO business, ai...

Onco-Innovations Bolsters Manufacturing, Regulatory and Capital Readiness for ONC010 Clinical Translation
Onco-Innovations Ltd. advances its oncology pipeline with key milestones in manufacturing, IND-enabling activities, partnerships, and funding, positio...

Roth Capital Partners Announces Extensive Schedule of Investor Events Through June 2027
Roth Capital Partners will host and sponsor over a dozen investor events, including seven ROTH-hosted conferences, from September 2026 to June 2027, c...

OS Animal Health Featured at Disruptive Growth & Life Sciences Conference
OS Animal Health, a subsidiary of OS Therapies, showcased its innovative HER2-targeting immunotherapy for canine osteosarcoma at the Moody Capital Sol...

Quantum BioPharma Gets FDA Clearance for First-in-Class MS Drug Trial
Quantum BioPharma's FDA clearance to test Lucid-MS in phase 2 trials marks a potential breakthrough in multiple sclerosis treatment by targeting myeli...

Laser Therapy Advances Offer New Hope for Brain Cancer Patients
A new study from Washington University School of Medicine highlights the growing role of laser interstitial thermal therapy (LITT) in brain cancer tre...

Ocumetics Begins Recruiting Patients for Group Two Human Clinical Surgeries, Advancing Beyond Safety into Vision Performance
Ocumetics Technology Corp. has initiated patient recruitment for its Group Two human clinical study, marking a critical step in evaluating the safety ...

Quantum BioPharma Gets FDA Clearance for First-in-Class MS Drug Targeting Myelin Repair
Quantum BioPharma's Lucid-MS, a first-in-class drug candidate for multiple sclerosis, has received FDA clearance for Phase 2 trials, potentially marki...

NanoViricides Registers Phase II Ebola Trial for Oral Gummies in DRC
NanoViricides has registered its Phase II clinical trial for NV-387 Oral Gummies as a treatment for Ebola in the Democratic Republic of Congo, marking...

Nutriband Advances Trademark Protection for Abuse-Deterrent Fentanyl Patch
Nutriband Inc. received a USPTO Notice of Publication for trademarks related to its abuse-deterrent fentanyl patch, moving closer to commercial launch...

Quantum BioPharma Advances MS Drug Candidate After FDA Clearance for Phase 2 Trial
Quantum BioPharma received FDA clearance to begin a Phase 2 trial for Lucid-MS, a novel multiple sclerosis treatment, marking a significant step towar...

Quantum BioPharma's Lucid-MS Receives FDA Clearance for Phase 2 Trial in Multiple Sclerosis
Quantum BioPharma's Lucid-MS has received FDA clearance for a Phase 2 trial in MS, marking a step toward a targeted treatment for demyelination.

Tonix Pharmaceuticals Promotes Thomas Englese to Chief Commercial Officer Amid TONMYA Launch
Tonix Pharmaceuticals has promoted Thomas Englese to Chief Commercial Officer to lead commercialization efforts for its fibromyalgia treatment TONMYA ...

Synbio International Inks Exclusive Licensing Deal for Nutraceuticals, Speeding Path to Revenue
Synbio International's exclusive licensing agreement with MD PHD Wellness provides immediate access to proprietary nutraceutical products, acceleratin...

AcroMeta to Enter Ambient Temperature Cellular Logistics Through Strategic Partnership With Macro HRD SG
AcroMeta Group announced a strategic partnership to acquire a stake in Macro-ATCLS and an option for exclusive Southeast Asian licensing of ambient-te...

Youth Tobacco Use Hits Historic Lows as FDA Authorizes ZYN Nicotine Pouches for Adult Smokers
New federal data shows youth tobacco use at historic lows, while FDA's recent authorization of ZYN nicotine pouches offers adult smokers a scientifica...

Flu Season Approaching: Experts Urge Vaccination and Prevention
As flu season nears, medical experts emphasize the importance of annual flu shots and preventive measures to protect individuals and communities.

AOM Capital Provides $3.8 Million Bridge Loan to Healthcare Firm Amid Reimbursement Delays
AOM Capital's $3.8 million bridge financing to a healthcare company highlights the growing need for short-term liquidity in the healthcare sector due ...

Nanox Imaging Expands U.S. Distribution with New England Partnership
Nanox Imaging has signed a distribution agreement with Associated X-Ray Imaging to expand the reach of its Nanox.ARC system in New England, potentiall...

Timing of Brain Metastases Predicts Survival in Colorectal Cancer Patients
A large study reveals that colorectal cancer patients who develop brain metastases have shorter survival, with timing significantly impacting prognosi...

SS Innovations Scales Surgical Robotics Globally as Revenue Jumps 39.4%
SS Innovations International reports strong quarterly growth and expanding global footprint, positioning its SSi Mantra system for potential U.S. and ...

Onco-Innovations Advances ONC010 Toward Clinical Trials with High-Purity Manufacturing and Australian Regulatory Pathway
Onco-Innovations reports significant progress in developing ONC010, a PNKP inhibitor for cancer therapy, including high-purity API production and plan...

VERAXA Biotech Appoints Seasoned Financial Executive Raju Willener as CFO to Drive Capital Strategy and Oncology Pipeline Growth
VERAXA Biotech AG (NASDAQ: VRXA) has appointed Raju Willener as CFO to lead its capital strategy and support the development of its proprietary BiTAC(...

AgeReverse to Present RESURGE Longevity Supplement at ECRM Session Amid U.S. Expansion
AgeReverse will showcase its RESURGE supplement at the ECRM Vitamin, Weight Management & Sports Nutrition Session, marking a key step in its U.S. mark...

Reztart Expands U.S. Availability to Amazon, Signaling Growing Mainstream Interest in Metabolic Health
Reztart, a Swedish metabolic nutrition brand, is preparing to launch on Amazon in the U.S., reflecting a broader consumer shift towards holistic metab...

CCHR Urges Greater Disclosure of Psychiatric Drugs' Violent and Suicidal Risks
The Citizens Commission on Human Rights calls for more thorough disclosure and informed consent regarding psychotropic drugs' potential violent and su...

BioVersys to Present at H.C. Wainwright 28th Annual Global Investment Conference
BioVersys, a clinical-stage biopharmaceutical company developing novel antibacterials for multi-drug resistant infections, will present a corporate ov...

OS Therapies to Present at Moody Capital Conference Amid Pivotal Regulatory Milestones for OST-HER2
OS Therapies is set to engage with investors at the Moody Capital conference while approaching critical regulatory decisions and data readouts for its...

Study Shows Immunotherapy Before Surgery May Improve Glioblastoma Outcomes
A preclinical study suggests that administering immunotherapy before tumor removal surgery could improve treatment outcomes for glioblastoma patients,...

Wolfson Group Highlights Evolving Trends in Men's Wellness Market
Wolfson Group notes a shift in men's wellness toward broader health and transparency, with TestoPrime expansion in the U.S. and retail meetings ahead.

Glocoms Inc. Expands Federal Healthcare with Aerospace Medicine Support at Joint Base San Antonio
Glocoms Inc. is strengthening its federal healthcare services by providing an Aerospace Medicine Physician to support the Defense Language Institute-E...
